Search results
Results from the WOW.Com Content Network
First, we should note that the stock was trading at a price-to-earnings ratio of over 100 earlier in 2024. Any stock trading at a nosebleed P/E is going to be risky, no matter how fast the company ...
Today, AbbVie stock trades at a forward price-to-earnings (P/E) ratio under 15. That's a solid deal for a company with 8% expected growth and a dividend yielding 3.5% at its current share price.
Buying the stock now sets investors up nicely for 2025, because I think the company can excel next year. Although Alphabet is the world's fourth-largest company by market cap, it still has plenty ...
Growth stocks have recently attracted investor interest. The Russell 3000 Growth Index returned 39.8% over the last year through Jan. 6. That was more than 24 percentage points better than the ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Taiwan Semiconductor Manufacturing wasn’t one of them. The 10 ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard Admiral Funds - Vanguard S&P 500 Value ETF wasn’t one ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dollar General wasn’t one of them. The 10 stocks that made the ...
2024 has been a great year for high-growth stocks. The Nasdaq-100 Index is up 23.4% year to date, with many stocks flying more than 100%. Recent investor favorite Celsius Holdings (NASDAQ: CELH ...